UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

JIN MEDICAL INTERNATIONAL LTD.

(Name of Issuer)

 

Ordinary Shares, Par Value $0.00005 Per Share

(Title of Class of Securities)

 

G5140V 112  

(CUSIP Number)

 

Erqi Wang

No. 33 Lingxiang Road, Wujin District

Changzhou City, Jiangsu Province

People’s Republic of China

+86-519 89607972

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

December 31, 2023

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

☐Rule 13d-1(b)

 

☐Rule 13d-1(c)

 

☒Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. G5140V 112

 

1.

NAMES OF REPORTING PERSONS

 

Erqi Wang

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

 

(a) ☐

(b) ☐

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

China

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH

 5.

SOLE VOTING POWER

 

107,126,140

6.

SHARED VOTING POWER

 

0

7.

SOLE DISPOSITIVE POWER

 

107,126,140

8.

SHARED DISPOSITIVE POWER

 

0

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

107,126,140 1

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(see instructions)   ☐

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

68.43%2

12.

TYPE OF REPORTING PERSON (see instructions)

 

IN

 

 

1Erqi Wang beneficially owns 95,381,140 Ordinary Shares through his 100% ownership of Jolly Harmony Enterprises Limited, and beneficially owns 11,745,000 Ordinary Shares through his 67% ownership of Er Pu International Limited. In total, Erqi Wang beneficially owns total 107,126,140 Ordinary Shares of the Issuer.

 

2This percentage is calculated based on 7,827,355 Ordinary Shares issued and outstanding as of January 12, 2024, as set forth in the Issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on February 1, 2024, and adjusted for a 20-for-1 forward stock split on February 8, 2024, resulting in the current outstanding shares being 156,547,100 shares.

 

2

 

 

CUSIP No. G5140V 112

 

1.

NAMES OF REPORTING PERSONS

I.R.S. Identification Nos. of above persons (Entities only):

 

Jolly Harmony Enterprises Limited; EIN: N/A3

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

 

(a) ☐

(b) ☐

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

British Virgin Islands

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH

 5.

SOLE VOTING POWER

 

95,381,140

6.

SHARED VOTING POWER

 

0

7.

SOLE DISPOSITIVE POWER

 

95,381,140

8.

SHARED DISPOSITIVE POWER

 

0

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

95,381,140

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(see instructions)   ☐

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

60.93%4

12.

TYPE OF REPORTING PERSON (see instructions)

 

CO

 

 

3Jolly Harmony Enterprises Limited is a British Virgin Islands entity, and it does not possess an Employer Identification Number (EIN).

 

4This percentage is calculated based on 7,827,355 Ordinary Shares issued and outstanding as of January 12, 2024, as set forth in the Issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on February 1, 2024, and adjusted for a 20-for-1 forward stock split on February 8, 2024, resulting in the current outstanding shares being 156,547,100 shares.

 

3

 

 

CUSIP No. G5140V 112

 

1.

NAMES OF REPORTING PERSONS

I.R.S. Identification Nos. of above persons (Entities only):

 

Er Pu International Limited; EIN: N/A5

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

 

(a) ☐

(b) ☐

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

 

British Virgin Islands

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH

 5.

SOLE VOTING POWER

 

11,745,000

6.

SHARED VOTING POWER

 

0

7.

SOLE DISPOSITIVE POWER

 

11,745,000

8.

SHARED DISPOSITIVE POWER

 

0

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

11,745,000 6

10.

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(see instructions)   ☐

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

7.50%7

12.

TYPE OF REPORTING PERSON (see instructions)

 

CO

 

 

5Er Pu International Limited is a British Virgin Islands entity, and it does not possess an Employer Identification Number (EIN).

 

6This percentage is calculated based on 7,827,355 Ordinary Shares issued and outstanding as of January 12, 2024, as set forth in the Issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on February 1, 2024, and adjusted for a 20-for-1 forward stock split on February 8, 2024, resulting in the current outstanding shares being 156,547,100 shares.

 

4

 

 

Item 1.

 

 

 

 (a)

Name of Issuer

 

Jin Medical International Ltd.

     
  (b)

Address of Issuer’s Principal Executive Offices

 

No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, People’s Republic of China.

 

Item 2.

 

 

 

 (a)

Name of Person Filing

Erqi Wang

Jolly Harmony Enterprises Limited

Er Pu International Limited

     
  (b) Address or principal business office or, if none, residence
    Erqi Wang: No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, People’s Republic of China.
    Jolly Harmony Enterprises Limited: No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, People’s Republic of China.
   

Er Pu International Limited: No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, People’s Republic of China.

 

  (c)

Citizenship

Erqi Wang: China

Jolly Harmony Enterprises Limited: British Virgin Islands

Er Pu International Limited: British Virgin Islands

     
  (d)

Title of Class of Securities

Erqi Wang: Ordinary Shares

Jolly Harmony Enterprises Limited: Ordinary Shares

Er Pu International Limited: Ordinary Shares

     
  (e)

CUSIP Number

G5140V 112

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

 

 (a) ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
       
  (b) ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
       
  (c) ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
       
  (d) ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
       
  (e) ☐ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
       
  (f) ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
       
  (g) ☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
       
  (h) ☐ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
       
  (j) ☐ Group, in accordance with §240.13d-1(b)(1)(ii)(J).

 

5

 

 

Item 4. Ownership.

 

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a)  

Amount beneficially owned:

See response to Item 9 on each cover page.

         
  (b)  

Percent of class8:  

See response to Item 11 on each cover page.

         
  (c)   Number of shares as to which the person has:  
         
      (i)

Sole power to vote or to direct the vote.

See response to Item 5 on each cover page.

         
      (ii)

Shared power to vote or to direct the vote.

See response to Item 6 on each cover page.

         
      (iii)

Sole power to dispose or to direct the disposition of.

See response to Item 7 on each cover page.

         
      (iv)

Shared power to dispose or to direct the disposition of.  

See response to Item 8 on each cover page.

 

Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

 

Item 5. Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following     ☐ .

 

Instruction. Dissolution of a group requires a response to this item.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

 

Not applicable.

 

 

8This percentage is calculated based on 7,827,355 Ordinary Shares issued and outstanding as of January 12, 2024, as set forth in the Issuer’s current report on Form 6-K filed with the Securities and Exchange Commission on February 1, 2024, and adjusted for a 20-for-1 forward stock split on February 8, 2024, resulting in the current outstanding shares being 156,547,100 shares.

 

6

 

 

Item 8. Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9. Notice of Dissolution of Group.

 

Not applicable.

 

Item 10. Certification.

 

  (a)   The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):
       
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
       
  (b)   The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):
       
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

7

 

 

CUSIP No. G5140V 112

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  Erqi Wang
   
  2/14/2024
  Date
   
  /s/ Erqi Wang
  Signature
   
  Erqi Wang/Individual
  Name/Title

 

  Jolly Harmony Enterprises Limited
   
  2/14/2024
  Date
   
  /s/ Erqi Wang
  Signature
   
  Erqi Wang/Director
  Name/Title

 

  Er Pu International Limited
   
  2/14/2024
  Date
   
  /s/ Erqi Wang
  Signature
   
  Erqi Wang/Director
  Name/Title

 

8

 

 

LIST OF EXHIBITS

 

Exhibit No.   Description
99.1   Joint Filing Agreement

 

 

9

 

Exhibit 99.1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary shares, par value of US$0.00005 per share, of Jin Medical International Ltd., a Cayman Islands exempted company, and that this Agreement may be included as an exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

 

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as of February 14, 2024.

 

  Erqi Wang
   
  2/14/2024
  Date
   
  /s/ Erqi Wang
  Signature
   
  Erqi Wang/Individual
  Name/Title

 

  Jolly Harmony Enterprises Limited
   
  2/14/2024
  Date
   
  /s/ Erqi Wang
  Signature
   
  Erqi Wang/Director
  Name/Title

 

  Er Pu International Limited
   
  2/14/2024
  Date
   
  /s/ Erqi Wang
  Signature
   
  Erqi Wang/Director
  Name/Title

 

Jin Medical (NASDAQ:ZJYL)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Jin Medical Charts.
Jin Medical (NASDAQ:ZJYL)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Jin Medical Charts.